drugset / Trial / NCT01053039

The Use of Intrathecal Morphine in the Management of Acute Pain Following Decompressive Lumbar Spinal Surgery

NCT01053039 ↗

Phase 4 Completed 150 enrolled University of Calgary
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary aim of this study is to assess the impact of intrathecal morphine on post-operative pain following instrumented fusion for degenerative lumbar spine disease. Secondary objectives of this study aim to assess side effects, overall narcotic use and duration of hospital stay following administration of intrathecal morphine. Based on our literature review, we expect a significant improvement in pain scores and functional status and minimal side effects with the use of intrathecal morphine. With improved pain and function we would also expect shorter hospital stays in those patients receiving intrathecal morphine.

Timeline

Start
2010-01
Primary completion
2014-11
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified 0.2 mg Intrathecal

Indications

No indication recorded.